These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 1487552)

  • 1. Pyrazinoylguanidine: antihypertensive, hypocholesterolemic, and renin effects.
    Chambers CE; Vesell ES; Helm C; Passananti GT; Beyer KH
    J Clin Pharmacol; 1992 Dec; 32(12):1128-34. PubMed ID: 1487552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrazinoylguanidine downregulates the glucose fatty-acid cycle in hypertensive, hyperinsulinemic diabetic patients.
    Vesell ES; Chambers CE; Seaton TD; Passananti GT; Demers LM; Beyer KH
    J Clin Pharmacol; 1994 Dec; 34(12):1234-45. PubMed ID: 7738221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amlodipine in ambulatory hypertensive patients: humoral and haemodynamic effects.
    Letizia C; De Ciocchis A; Cerci S; Coassin S; Fisher H; Tarsitani P; Scavo D
    Int J Clin Pharmacol Res; 1993; 13(3):151-9. PubMed ID: 8225698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on pyrazinoylguanidine. 7. Effects of single oral doses in normal human subjects.
    Vesell ES; Beyer KH
    Pharmacology; 1999 Mar; 58(3):140-6. PubMed ID: 9925970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: a multicenter, 12-week, double-blind, double-dummy, parallel-group superiority study.
    Rump LC; Baranova E; Okopien B; Weisskopf M; Kandra A; Ferber P
    Clin Ther; 2008 Oct; 30(10):1782-93. PubMed ID: 19014834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nisoldipine on sympathetic activity, the renin-angiotensin-aldosterone system, and water-sodium-calcium metabolism in patients with essential hypertension.
    Iimura O; Kikuchi K; Shimamoto K; Nozawa A; Hasegawa R; Homma C; Komura H; Kobayakawa H
    Arzneimittelforschung; 1989 Jun; 39(6):710-4. PubMed ID: 2775339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel multivalent effects of pyrazinoylguanidine in patients with azotemia.
    Beyer KH; Gelarden RT; Vary JE; Brown LE; Vesell ES
    Clin Pharmacol Ther; 1990 May; 47(5):629-38. PubMed ID: 2188773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fosinopril on the blood pressure and lipid profile of patients undergoing heart transplantation.
    Almenar L; Osa A; Palencia M; Flores A; Sánchez E
    J Heart Lung Transplant; 1997 Apr; 16(4):454-9. PubMed ID: 9154957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between serum cholesterol levels and the renin-angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure.
    Borghi C; Veronesi M; Cosentino E; Cicero AF; Kuria F; Dormi A; Ambrosioni E
    J Hypertens; 2007 Oct; 25(10):2051-7. PubMed ID: 17885547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship of the renin-angiotensin-aldosterone system with auricular natriuretic factor in its response to the action of thiazide diuretics and to nifedipine, a sustained-release calcium antagonist].
    Ocón J; Mora-Macià J; Castellet R; del Río G
    Med Clin (Barc); 1994 Jan; 102(2):41-5. PubMed ID: 8133694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on pyrazinoylguanidine: a novel antihypertensive, hypoglycemic and lipolytic drug intended for adjunctive use in hypertensive patients with type 2 diabetes mellitus.
    Vesell ES; Beyer KH
    Toxicology; 2000 Apr; 144(1-3):5-11. PubMed ID: 10781866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting effects of pyrazinoylguanidine and hydrochlorothiazide in patients with renal insufficiency.
    Beyer KH; Ward TD; Vary JE; Gelarden RT; Knutson DW; Vesell ES
    J Clin Pharmacol; 1993 Jun; 33(6):554-61. PubMed ID: 8366180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of slow-release nicardipine on blood pressure, renal function and the renin-angiotensin-aldosterone system in patients with mild-to-moderate essential arterial hypertension].
    Melina D; Guerrera G; Santoliquido A; Colivicchi F; Melina G; Musumeci V; Guerrera C
    Clin Ter; 1991 Nov 15-30; 139(3-4):101-6. PubMed ID: 1837249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
    Berioli S; Bentivoglio M; Conti R; Osanna RA; Savino K; Zollino L; Corea L
    Cardiologia; 1990 Apr; 35(4):335-40. PubMed ID: 2245435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of fish oil, nifedipine and their combination on blood pressure and lipids in primary hypertension.
    Landmark K; Thaulow E; Hysing J; Mundal HH; Eritsland J; Hjermann I
    J Hum Hypertens; 1993 Feb; 7(1):25-32. PubMed ID: 8450517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pinacidil on serum lipid, lipoprotein, and apolipoprotein levels in patients with mild to moderate hypertension.
    Saku K; Ying H; Arakawa K
    Clin Ther; 1990; 12(2):132-8. PubMed ID: 2354482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on pyrazinoylguanidine. 1. Characterization of metabolic effects in diabetic rats.
    A-Rahim YI; Beyer KH; Vesell ES
    Pharmacology; 1996 Mar; 52(3):135-44. PubMed ID: 8849482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pyrazinoylguanidine on the glucose-fatty acid cycle in normal subjects and patients with non-insulin-dependent diabetes mellitus.
    Vesell ES; Chambers CE; Passananti GT; Demers LM; Beyer KH
    J Clin Pharmacol; 1993 Sep; 33(9):823-31. PubMed ID: 8227479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.